中华心血管病杂志
中華心血管病雜誌
중화심혈관병잡지
Chinese Journal of Cardiology
2014年
1期
43-47
,共5页
内皮细胞%斯伐他汀%脂蛋白类,LDL%氧化性应激
內皮細胞%斯伐他汀%脂蛋白類,LDL%氧化性應激
내피세포%사벌타정%지단백류,LDL%양화성응격
Endothelial cells%Simvastatin%Lipoproteins,LDL%Oxidative stress
目的 观察辛伐他汀对氧化型低密度脂蛋白(oxidized low-density lipoprotein,ox-LDL)诱导的内皮细胞氧化应激损伤的保护作用,并初步探讨其机制.方法 体外分离培养人脐静脉内皮细胞后分为6组,分别是对照组、ox-LDL处理组(ox-LDL组)、辛伐他汀溶剂+ox-LDL组(溶剂对照组),辛伐他汀0.1 μmol/L+ ox-LDL组、辛伐他汀0.5 μmol/L+ ox-LDL组和辛伐他汀1.0 μmol/L+ox-LDL组.ox-LDL处理组直接给予ox-LDL(120 μg/ml)刺激24 h.辛伐他汀+ox-LDL组分别采用不同浓度的辛伐他汀(0.1、0.5和1.0 μmol/L)预先孵育人脐静脉内皮细胞30 rin,再给予ox-LDL(120 μg/ml)刺激24 h.荧光分光光度法测定胞内活性氧簇(ROS)的水平.化学发光法测定胞内还原型烟酰胺腺嘌呤二核苷酸磷酸氧化酶(NADPH氧化酶)活性.RT-PCR测定NADPH氧化酶亚基p22phox、gp91phox、p47phox和p67phoxmRNA的表达水平.免疫共沉淀以及免疫印迹方法测定p47 phox与p22phox(p47 phox/p22phox)的蛋白结合量.结果 ox-LDL组ROS水平和NADPH氧化酶活性均显著高于对照组[分别为1.507±0.048比0.442±0.021(P<0.01)和(87.90±10.34) RLU·s-1·mg-1比(38.52±4.20) RLU·s-1·mg-1(P<0.01)],p22phox、gp91 phox、p47phox和p67phox mRNA水平亦均显著高于对照组(P均<0.01),p47 phox/p22 phox蛋白结合量亦显著高于对照组[(292±12)%比100%,P<0.01].辛伐他汀不同浓度+ox-LDL各组ROS水平和NADPH氧化酶活性随着辛伐他汀浓度的增加而降低,组间差异均有统计学意义(P均<0.05),且均低于ox-LDL组(P<0.05或0.01).辛伐他汀1.0 μmol/L+ ox-LDL组p22phox、gp91phox、p47phox和p67phoxmRNA水平均显著低于ox-LDL组(P均<0.05),p47phox/p22phox蛋白结合量亦显著低于ox-LDL组[(117±9)%比(292±l2)%,P<0.01].结论 辛伐他汀可能通过降低NADPH氧化酶活性的途径保护ox-LDL诱导的内皮细胞氧化应激损伤,其机制可能与下调NADPH氧化酶亚基mRNA表达水平和抑制p47phox/p22phox蛋白结合有关.
目的 觀察辛伐他汀對氧化型低密度脂蛋白(oxidized low-density lipoprotein,ox-LDL)誘導的內皮細胞氧化應激損傷的保護作用,併初步探討其機製.方法 體外分離培養人臍靜脈內皮細胞後分為6組,分彆是對照組、ox-LDL處理組(ox-LDL組)、辛伐他汀溶劑+ox-LDL組(溶劑對照組),辛伐他汀0.1 μmol/L+ ox-LDL組、辛伐他汀0.5 μmol/L+ ox-LDL組和辛伐他汀1.0 μmol/L+ox-LDL組.ox-LDL處理組直接給予ox-LDL(120 μg/ml)刺激24 h.辛伐他汀+ox-LDL組分彆採用不同濃度的辛伐他汀(0.1、0.5和1.0 μmol/L)預先孵育人臍靜脈內皮細胞30 rin,再給予ox-LDL(120 μg/ml)刺激24 h.熒光分光光度法測定胞內活性氧簇(ROS)的水平.化學髮光法測定胞內還原型煙酰胺腺嘌呤二覈苷痠燐痠氧化酶(NADPH氧化酶)活性.RT-PCR測定NADPH氧化酶亞基p22phox、gp91phox、p47phox和p67phoxmRNA的錶達水平.免疫共沉澱以及免疫印跡方法測定p47 phox與p22phox(p47 phox/p22phox)的蛋白結閤量.結果 ox-LDL組ROS水平和NADPH氧化酶活性均顯著高于對照組[分彆為1.507±0.048比0.442±0.021(P<0.01)和(87.90±10.34) RLU·s-1·mg-1比(38.52±4.20) RLU·s-1·mg-1(P<0.01)],p22phox、gp91 phox、p47phox和p67phox mRNA水平亦均顯著高于對照組(P均<0.01),p47 phox/p22 phox蛋白結閤量亦顯著高于對照組[(292±12)%比100%,P<0.01].辛伐他汀不同濃度+ox-LDL各組ROS水平和NADPH氧化酶活性隨著辛伐他汀濃度的增加而降低,組間差異均有統計學意義(P均<0.05),且均低于ox-LDL組(P<0.05或0.01).辛伐他汀1.0 μmol/L+ ox-LDL組p22phox、gp91phox、p47phox和p67phoxmRNA水平均顯著低于ox-LDL組(P均<0.05),p47phox/p22phox蛋白結閤量亦顯著低于ox-LDL組[(117±9)%比(292±l2)%,P<0.01].結論 辛伐他汀可能通過降低NADPH氧化酶活性的途徑保護ox-LDL誘導的內皮細胞氧化應激損傷,其機製可能與下調NADPH氧化酶亞基mRNA錶達水平和抑製p47phox/p22phox蛋白結閤有關.
목적 관찰신벌타정대양화형저밀도지단백(oxidized low-density lipoprotein,ox-LDL)유도적내피세포양화응격손상적보호작용,병초보탐토기궤제.방법 체외분리배양인제정맥내피세포후분위6조,분별시대조조、ox-LDL처리조(ox-LDL조)、신벌타정용제+ox-LDL조(용제대조조),신벌타정0.1 μmol/L+ ox-LDL조、신벌타정0.5 μmol/L+ ox-LDL조화신벌타정1.0 μmol/L+ox-LDL조.ox-LDL처리조직접급여ox-LDL(120 μg/ml)자격24 h.신벌타정+ox-LDL조분별채용불동농도적신벌타정(0.1、0.5화1.0 μmol/L)예선부육인제정맥내피세포30 rin,재급여ox-LDL(120 μg/ml)자격24 h.형광분광광도법측정포내활성양족(ROS)적수평.화학발광법측정포내환원형연선알선표령이핵감산린산양화매(NADPH양화매)활성.RT-PCR측정NADPH양화매아기p22phox、gp91phox、p47phox화p67phoxmRNA적표체수평.면역공침정이급면역인적방법측정p47 phox여p22phox(p47 phox/p22phox)적단백결합량.결과 ox-LDL조ROS수평화NADPH양화매활성균현저고우대조조[분별위1.507±0.048비0.442±0.021(P<0.01)화(87.90±10.34) RLU·s-1·mg-1비(38.52±4.20) RLU·s-1·mg-1(P<0.01)],p22phox、gp91 phox、p47phox화p67phox mRNA수평역균현저고우대조조(P균<0.01),p47 phox/p22 phox단백결합량역현저고우대조조[(292±12)%비100%,P<0.01].신벌타정불동농도+ox-LDL각조ROS수평화NADPH양화매활성수착신벌타정농도적증가이강저,조간차이균유통계학의의(P균<0.05),차균저우ox-LDL조(P<0.05혹0.01).신벌타정1.0 μmol/L+ ox-LDL조p22phox、gp91phox、p47phox화p67phoxmRNA수평균현저저우ox-LDL조(P균<0.05),p47phox/p22phox단백결합량역현저저우ox-LDL조[(117±9)%비(292±l2)%,P<0.01].결론 신벌타정가능통과강저NADPH양화매활성적도경보호ox-LDL유도적내피세포양화응격손상,기궤제가능여하조NADPH양화매아기mRNA표체수평화억제p47phox/p22phox단백결합유관.
Objective To investigate the effects and related mechanism of simvastatin on oxidized low density lipoprotein (ox-LDL) induced oxidative stress in human umbilical vein endothelial cells (HUVECs).Methods HUVECs were cultured in 6 different culture media:control,ox-LDL,ox-LDL + vehicle,ox-LDL + 0.1 μmol/L simvastatin,ox-LDL + 0.5 μmol/L simvastatin,ox-LDL + 1.0 μmol/L simvastatin.HUVECs were incubated with ox-LDL (120 μg/ml) for 24 h in the presence or absence of different concentrations of simvastatin (0.1,0.5,1.0 μmol/L).The fluorescence intensity for reactive oxygen species (ROS) in HUVECs was measured by a laser confocal scanning microscopy and a microplate reader.NADPH oxidase activity was measured by lucigenin chemiluminescence,p22phox,gp91 phox,p47phox and p67phox mRNA expression of HUVECs post various treatments was detected by RT-PCR.p22phox immunoprecipitates were immunoblotted for p47phox and total p22phox levels to indentify p47phox/p22phox interaction.Results Simvastatin attenuated ox-LDL induced ROS generation and NADPH oxidase activity in a concentration dependent manner (all P < 0.05).In addition,simvastatin significantly downregulated mRNA expression of p22phox,gp91phox,p47phox and p67phox (all P < 0.05),as well as the interaction of p47phox/p22phox (P < 0.01).Conclusions Simvastatin is an important regulator on NADPH subunits mRNA expressions and p47phox/p22phox interaction.Simvastatin attenuates ox-LDL-induced oxidative stress in HUVECs via reducing NADPH oxidase activity.